{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:58:58Z","timestamp":1777543138696,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"SEC-CNIC CARDIOJOVEN Program","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10557-018-6788-8","type":"journal-article","created":{"date-parts":[[2018,4,14]],"date-time":"2018-04-14T06:11:06Z","timestamp":1523686266000},"page":"127-133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Myocardial Infarct Size Reduction Provided by Local and Remote Ischaemic Preconditioning: References Values from the Hatter Cardiovascular Institute"],"prefix":"10.1007","volume":"32","author":[{"given":"Xavier","family":"Rossello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhe","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek M.","family":"Yellon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,14]]},"reference":[{"key":"6788_CR1","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1136\/bmj.328.7438.514","volume":"328","author":"P Pound","year":"2004","unstructured":"Pound P, Ebrahim S, Sandercock P, Bracken MB, Roberts I. Reviewing animal trials systematically (RATS) group. Where is the evidence that animal research benefits humans? BMJ. 2004;328:514\u20137.","journal-title":"BMJ"},{"key":"6788_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrcardio.2014.137","volume":"11","author":"V Fuster","year":"2014","unstructured":"Fuster V. Top 10 cardiovascular therapies and interventions for the next decade. Nat Rev Cardiol. 2014;11:671\u201383.","journal-title":"Nat Rev Cardiol"},{"key":"6788_CR3","unstructured":"Rossello X, Yellon DM. A critical review on the translational journey of cardioprotective therapies! Int J Cardiol. Elsevier; 2016;220:176\u201384."},{"key":"6788_CR4","first-page":"288","volume":"113","author":"DI Bromage","year":"2016","unstructured":"Bromage DI, Pickard JMJ, Rossello X, Ziff OJ, Burke N, Yellon DM, et al. Remote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia-reperfusion injury: a systematic review and meta-analysis. Cardiovasc Res. 2016;113:288\u201397.","journal-title":"Cardiovasc Res"},{"key":"6788_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00395-016-0529-6","volume":"111","author":"J Johnsen","year":"2016","unstructured":"Johnsen J, Pryds K, Salman R, L\u00f8fgren B, Kristiansen SB, B\u00f8tker HE. The remote ischemic preconditioning algorithm: effect of number of cycles, cycle duration and effector organ mass on efficacy of protection. Basic Res Cardiol. 2016;111:10.","journal-title":"Basic Res Cardiol"},{"key":"6788_CR6","doi-asserted-by":"publisher","first-page":"e0142021","DOI":"10.1371\/journal.pone.0142021","volume":"10","author":"KE Wever","year":"2015","unstructured":"Wever KE, Hooijmans CR, Riksen NP, Sterenborg TB, Sena ES, Ritskes-Hoitinga M, et al. Determinants of the efficacy of cardiac ischemic preconditioning: a systematic review and meta-analysis of animal studies. PLoS One. 2015;10:e0142021.","journal-title":"PLoS One"},{"key":"6788_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10557-016-6673-2","volume":"30","author":"X Rossello","year":"2016","unstructured":"Rossello X, Burke N, Stoppe C, Bernhagen J, Davidson SM, Yellon DM. Exogenous administration of recombinant MIF at physiological concentrations failed to attenuate infarct size in a Langendorff perfused isolated mouse heart model. Cardiovasc Drugs Ther. 2016;30:445\u201353.","journal-title":"Cardiovasc Drugs Ther"},{"key":"6788_CR8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/jcmm.13394","volume":"22","author":"X Rossello","year":"2017","unstructured":"Rossello X, Riquelme JA, Davidson SM, Yellon DM. Role of PI3K in myocardial ischaemic preconditioning: mapping pro-survival cascades at the trigger phase and at reperfusion. J Cell Mol Med. 2017;22:926\u201335.","journal-title":"J Cell Mol Med"},{"key":"6788_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00395-017-0657-7","volume":"112","author":"X Rossello","year":"2017","unstructured":"Rossello X, Riquelme JA, He Z, Taferner S, Vanhaesebroeck B, Davidson SM, et al. The role of PI3K\u03b1 isoform in cardioprotection. Basic Res Cardiol. 2017;112:66.","journal-title":"Basic Res Cardiol"},{"key":"6788_CR10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1177\/1074248415604462","volume":"21","author":"X Rossello","year":"2015","unstructured":"Rossello X, Hall AR, Bell RM, Yellon DM. Characterization of the Langendorff perfused isolated mouse heart model of global ischemia-reperfusion injury: impact of ischemia and reperfusion length on infarct size and LDH release. J Cardiovasc Pharmacol Ther. 2015;21:286\u201395.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"6788_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/BF00430828","volume":"393","author":"HH Klein","year":"1981","unstructured":"Klein HH, Puschmann S, Schaper J, Schaper W. Vircho Archiv A the mechanism of the tetrazolium reaction in identifying experimental myocardial infarction. Virchows Arch [Pathol Anat]. 1981;393:287\u201397.","journal-title":"Virchows Arch [Pathol Anat]"},{"key":"6788_CR12","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8:e1000412.","journal-title":"PLoS Biol"},{"key":"6788_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jacc.2014.10.031","volume":"65","author":"G Heusch","year":"2015","unstructured":"Heusch G, B\u00f8tker HE, Przyklenk K, Redington A, Yellon D. Remote ischemic conditioning. J Am Coll Cardiol. 2015;65:177\u201395.","journal-title":"J Am Coll Cardiol"},{"key":"6788_CR14","doi-asserted-by":"crossref","unstructured":"Wever KE, Menting TP, Rovers M, van der Vliet JA, Rongen GA, Masereeuw R, Ritskes-Hoitinga M, Hooijmans CR, Warl\u00e9 M. Ischemic preconditioning in the animal kidney, a systematic review and meta-analysis. Eltzschig HK, editor. PLoS One 2012;7:e32296.","DOI":"10.1371\/journal.pone.0032296"},{"key":"6788_CR15","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1161\/CIRCULATIONAHA.116.022829","volume":"134","author":"X Rossello","year":"2016","unstructured":"Rossello X, Yellon DM. Cardioprotection: the disconnect between bench and bedside. Circulation. 2016;134:574\u20135.","journal-title":"Circulation"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-018-6788-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-018-6788-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-018-6788-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:59:58Z","timestamp":1720227598000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-018-6788-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["6788"],"URL":"https:\/\/doi.org\/10.1007\/s10557-018-6788-8","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"14 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on the Welfare of Animals"}}]}}